Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CDC Cautions State Health Officials Not to Give COVID Boosters Until FDA Regulatory Action and CDC Recommendation: Washington Post

09/17/2021 | 12:30pm EDT


ę MT Newswires 2021
All news about MODERNA, INC.
05:09aModerna Announces European Medicines Agency's Committee for Medicinal Products for Huma..
AQ
05:00aModerna to supply Africa with up to 110 million COVID doses
AQ
03:35aMODERNA : Signs Memorandum of Understanding With African Union for Supply of Up to 110 Mil..
MT
01:24aMODERNA : Announces Memorandum of Understanding to Supply up to 110 Million Doses of Its C..
BU
12:27aFifteen mln doses of moderna vaccine to be delivered to the african union in q4 of 2021..
RE
12:27aMODERNA : African Union to buy up to 110 million Moderna COVID-19 vaccines -officials
RE
12:27aModerna will supply african union with up to 110 million covid-19 vaccine doses - compa..
RE
12:27aU.s. will defer delivery of 33 million moderna vaccines it has purchased so that africa..
RE
10/25MODERNA : European Medicines Agency Backs Moderna's COVID-19 Booster Jab
MT
10/25SAMSUNG BIOLOGICS : S.Korea approves Moderna's COVID-19 vaccine produced by Samsung Biolog..
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 374 M - -
Net income 2021 12 558 M - -
Net cash 2021 13 559 M - -
P/E ratio 2021 11,7x
Yield 2021 -
Capitalization 141 B 141 B -
EV / Sales 2021 6,26x
EV / Sales 2022 5,55x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 349,56 $
Average target price 295,79 $
Spread / Average Target -15,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.234.60%141 099
LONZA GROUP AG31.93%60 646
IQVIA HOLDINGS INC.43.58%49 145
SEAGEN INC.0.22%31 933
CELLTRION, INC.-39.69%25 328
ALNYLAM PHARMACEUTICALS, INC.53.63%23 730